Clinuvel Pharmaceuticals Ltd (OTCPK:CLVLF)
$ 8.45 0 (0%) Market Cap: 379.76 Mil Enterprise Value: 265.51 Mil PE Ratio: 17.35 PB Ratio: 2.99 GF Score: 90/100

Half Year 2022 Clinuvel Pharmaceuticals Ltd Earnings Call Transcript

Feb 23, 2022 / 07:00AM GMT
Release Date Price: $15.75 (-5.41%)
Verity Wai;Smith
Monsoon Communications - IR

Good evening. I'm Verity Wai-Smith from Monsoon Communications. Thank you for joining us for CLINUVEL'S half-year report investor presentation. I'll now hand over to Malcolm Bull to begin.

Malcolm Bull
CLINUVEL - Head of IR

Thank you, Verity. And greetings to all who have taken time to join us today. It's my pleasure to discuss the financial results for the half year to December 31, 2021, and more generally, the growth and expansion of the CLINUVEL group. And I'm discussing that with Darren Keamy and Lachlan Hay.

Before progressing further, participants should please note that we will be talking about our plans and making forward-looking statements. So I'll briefly highlight our legal notice, which outlines that there are many risks that can impact the achievement of plans. And a copy of these notices is on our website and accompanies every company announcement. So many of you will be familiar with it.

Also, unless otherwise stated, any references we make today to dollars refer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot